United-Guardian (UG) Stock Price, News & Analysis

Company Overview

United-Guardian, Inc. is a specialty chemicals company that develops, manufactures and markets products for the personal care, pharmaceutical and industrial markets. The company serves customers in the United States and international markets through direct sales, distributors and commercial partners.

Its personal care portfolio includes Lubrajel, a family of water-based moisturizing and lubricating gels used in skin-care, hair-care, cosmetic and personal lubricant formulations. United-Guardian also supplies specialty ingredients designed to improve the texture, moisture retention and performance of finished consumer products.

In the pharmaceutical sector, the company markets Renacidin, a solution used under medical supervision for certain urinary tract applications, including the prevention and dissolution of specific types of urinary encrustations and stones. Its industrial products are used in areas such as water treatment, lubricants and other specialty chemical applications. United-Guardian was established in 1942 and is headquartered in Hauppauge, New York.

Key Stats

• Today's Range: $8.37 to $9.48
• 50-Day Range: $6.64 to $9.16
• 52-Week Range: $5.58 to $9.95
• Volume: 20,379 shs
• Average Volume: 21,143 shs
• Market Capitalization: $39.61 million
• P/E Ratio: 12.63
• Dividend Yield: 6.95%
• Price Target: N/A
• Consensus Rating: Hold

United-Guardian Stock Analysis - MarketRank™

United-Guardian scored higher than 31% of companies evaluated by MarketBeat, and ranked 766th out of 892 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 1.2 / 5
• Analyst Rating: Hold

Consensus Rating

United-Guardian has received a consensus rating of Hold. The company's average rating score is 2.00, and is based on no strong buy ratings, no buy ratings, 1 hold rating, and no sell ratings.

Amount of Analyst Coverage

United-Guardian has only been the subject of 1 research reports in the past 90 days.

Earnings and Valuation

• Score: 1.3 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of United-Guardian is 12.63, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 25.28.

Price to Earnings Ratio vs. Sector

The P/E ratio of United-Guardian is 12.63, which means that it is trading at a less expensive P/E ratio than the Healthcare sector average P/E ratio of about 34.32.

Price to Book Value per Share Ratio

United-Guardian has a P/B Ratio of 3.54. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

0.19% of the float of United-Guardian has been sold short.

Short Interest Ratio / Days to Cover

United-Guardian has a short interest ratio ("days to cover") of 0.97, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in United-Guardian has recently increased by 14.40%, indicating that investor sentiment is decreasing significantly.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Leadership

United-Guardian is a leading dividend payer. It pays a dividend yield of 6.98%, putting its dividend yield in the top 25% of dividend-paying stocks.

Dividend Growth

United-Guardian has only been increasing its dividend for 1 years.

Dividend Coverage

The dividend payout ratio of United-Guardian is 88.24%. Payout ratios above 75% are not desirable because they may not be sustainable.

News and Social Media

• Score: 2.3 / 5
• News Sentiment: 0.65

News Sentiment

United-Guardian has a news sentiment score of 0.65. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Healthcare companies.

News Coverage This Week

MarketBeat has tracked 5 news articles for United-Guardian this week, compared to 0 articles on an average week.

Company Ownership

• Score: 1.0 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, United-Guardian insiders have not sold or bought any company stock.

Percentage Held by Insiders

29.00% of the stock of United-Guardian is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

23.16% of the stock of United-Guardian is held by institutions.

Company Calendar

• Last Earnings: 11/09/2026
• Today: 11/12/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: NASDAQ:UG
• CIK: 101295
• Web: www.u-g.com
• Phone: (631) 273-0900
• Fax: 631-273-0858
• Employees: 25
• Year Founded: 1942

Profitability

• EPS (Trailing Twelve Months): $0.68
• Trailing P/E Ratio: 12.63
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: $2.11 million
• Net Margins: 25.16%
• Pretax Margin: 27.62%
• Return on Equity: 27.80%
• Return on Assets: 23.82%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 7.32
• Quick Ratio: 6.64

Sales & Book Value

• Annual Sales: $10.55 million
• Price / Sales: 3.75
• Cash Flow: $0.48 per share
• Price / Cash Flow: 17.82
• Book Value: $2.44 per share
• Price / Book: 3.54

Miscellaneous

• Outstanding Shares: 4,590,000
• Free Float: N/A
• Market Cap: $39.61 million
• Optionable: Not Optionable
• Beta: 0.99